Pfizer to make obesity drug

London - The maker of impotency drug Viagra could be about to make another fortune with a new medicine being developed in Cambridge to combat obesity, it emerged yesterday. American drugs group Pfizer has signed a £24 million licensing and development deal with Cambridge research outfit Phytopharm to develop an appetite-suppressing chemical derived from a South African plant.